Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Etienne Brain

Showing results (51-60 of 139) with videos related to

Pageof 14
Sort By:
Journal of Pain and Symptom Management|August 14, 2024
Serious Health-Related Suffering Impairs Treatments and Survival in Older Patients With CancerMatthieu Frasca, Claudia Martinez-Tapia, Charline Jean, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2010
Trastuzumab treatment in t1ab, node-negative, human epidermal growth factor receptor 2-overexpressing breast carcinomasManuel Jorge Rodrigues, Johanna Wassermann, Laurence Albiges, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2025
Prognostic Significance and Predictive Value of Circulating Tumor Cells in Invasive Lobular Breast Carcinoma-An Exploratory Analysis of the STIC CTC TrialJose Luis Sandoval, Nicolas Kiavue, Lounes Djerroudi, et al.
British Journal of Cancer|January 21, 2021
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trialLuc Cabel, Frédérique Berger, Paul Cottu, et al.
The Lancet. Oncology|April 4, 2012
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)Laura Biganzoli, Hans Wildiers, Catherine Oakman, et al.
The Lancet. Healthy Longevity|January 10, 2026
Defining and addressing loneliness in older adults with cancer: an international Delphi consensus from the Multinational Association of Supportive Care in Cancer Geriatrics Study GroupEnrique Soto-Perez-de-Celis, Kristen R Haase, Sriram Yennu, et al.
Journal of Geriatric Oncology|February 1, 2022
Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trialLissandra Dal Lago, Aimé Lambert Uwimana, Corneel Coens, et al.
Journal of Geriatric Oncology|August 3, 2020
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 - EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measuresIcro Meattini, Philip M P Poortmans, Livia Marrazzo, et al.
Journal of Geriatric Oncology|September 7, 2023
Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiativeAngéline Galvin, Pierre Soubeyran, Etienne Brain, et al.
Breast Cancer Research : BCR|September 15, 2020
Plasma thymidine kinase 1 activity and outcome of ER+ HER2- metastatic breast cancer patients treated with palbociclib and endocrine therapyLuc Cabel, Dan Rosenblum, Florence Lerebours, et al.
Pageof 14

Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
Journal of Pain and Symptom Management|August 14, 2024
Serious Health-Related Suffering Impairs Treatments and Survival in Older Patients With CancerMatthieu Frasca, Claudia Martinez-Tapia, Charline Jean, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2010
Trastuzumab treatment in t1ab, node-negative, human epidermal growth factor receptor 2-overexpressing breast carcinomasManuel Jorge Rodrigues, Johanna Wassermann, Laurence Albiges, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2025
Prognostic Significance and Predictive Value of Circulating Tumor Cells in Invasive Lobular Breast Carcinoma-An Exploratory Analysis of the STIC CTC TrialJose Luis Sandoval, Nicolas Kiavue, Lounes Djerroudi, et al.
British Journal of Cancer|January 21, 2021
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trialLuc Cabel, Frédérique Berger, Paul Cottu, et al.
The Lancet. Oncology|April 4, 2012
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)Laura Biganzoli, Hans Wildiers, Catherine Oakman, et al.
The Lancet. Healthy Longevity|January 10, 2026
Defining and addressing loneliness in older adults with cancer: an international Delphi consensus from the Multinational Association of Supportive Care in Cancer Geriatrics Study GroupEnrique Soto-Perez-de-Celis, Kristen R Haase, Sriram Yennu, et al.
Journal of Geriatric Oncology|February 1, 2022
Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trialLissandra Dal Lago, Aimé Lambert Uwimana, Corneel Coens, et al.
Journal of Geriatric Oncology|August 3, 2020
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 - EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measuresIcro Meattini, Philip M P Poortmans, Livia Marrazzo, et al.
Journal of Geriatric Oncology|September 7, 2023
Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiativeAngéline Galvin, Pierre Soubeyran, Etienne Brain, et al.
Breast Cancer Research : BCR|September 15, 2020
Plasma thymidine kinase 1 activity and outcome of ER+ HER2- metastatic breast cancer patients treated with palbociclib and endocrine therapyLuc Cabel, Dan Rosenblum, Florence Lerebours, et al.
Pageof 14